(Q52881005)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

G R Thompson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

S Matthews

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Y Kitano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

C Neuwirth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M B Shortt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

G Davies

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

A Rees

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

A Mir

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

R J Prescott

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 April 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

8953

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

811-816

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

28 October 2019

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Plasma exchange in the management of homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Assessment of long-term plasma exchange for familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Relation between Myocardial Blood Flow and the Severity of Coronary-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Advances in LDL-apheresis for the treatment of severe hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

A prospective study of lipoprotein(a) and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Raised serum lipoprotein during treatment with lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

Association between lipoprotein(a) and progression of coronary artery disease in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992961-4

7 January 2021

10.1016/S0140-6736(95)92961-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7898227%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference